BioCentury
ARTICLE | Clinical News

Bedoradrine: Completed Phase II enrollment

March 26, 2012 7:00 AM UTC

MediciNova completed enrollment of 176 patients in a double-blind, placebo-controlled, U.S. Phase II (MN-221-CL-007) trial evaluating 1,200 µg IV MN-221. The company has exclusive, ex-Japanese rights ...